ロード中...
Soy Isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial
BACKGROUND: Soy isoflavone consumption may protect against breast cancer development. We conducted a Phase IIB trial of soy isoflavone supplementation, to examine its effect on breast epithelial proliferation and other biomarkers in the healthy high risk breast. METHODS: 126 consented women underwen...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3333836/ https://ncbi.nlm.nih.gov/pubmed/22307566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-11-0251 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|